VRDN (US) share price forecast & AI signal — Viridian Therapeutics, Inc
Week of 2026-10-30 · Healthcare
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in VRDN
Viridian Therapeutics, Inc is a Healthcare stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a BUY with low confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About Viridian Therapeutics, Inc
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered, and Elegrobart, a low-volume, infrequently dosed subcutaneous IGF-1R. The company also develops an anti-thyroid-stimulating hormone receptor (TSHR) candidate for the treatment of Graves' disease and TED. Its portfolio of engineered inhibitors of the neonatal Fc receptor (FcFn) includes VRDN-006, a highly selective Fc fragment, and VRDN-008, a half-life extended bispecific FcRn inhibitor...
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $28.49 |
| 2026-11-05 | $28.55 |
| 2026-11-04 | $29.05 |
| 2026-11-03 | $25.15 |
| 2026-11-02 | $25.30 |
| 2026-10-30 | $24.67 |
| 2026-10-29 | $24.80 |
VRDN FAQ
Is Viridian Therapeutics, Inc (VRDN) a buy or sell this week?
The ACE Stock Bots machine-learning model rates VRDN a BUY for the week of 2026-10-30 with low confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for VRDN?
Every week the model scores VRDN across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Healthcare stocks on the US
This week's top US picks · All US stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.